This inventor holds 1 USPTO granted patent. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitaet Heidelberg, Universitaetsklinikum Heidelberg. Active years: 2017.
Company Filing History:
1 out of 159 
1 out of 23 
1 out of 4 Years Active: 2017
Title: Celina Czeipluch: Innovator in Cancer Treatment
Introduction
Celina Czeipluch is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on improving patient responses to chemovirotherapy and radiovirotherapy.
Latest Patents
Celina holds a patent for "Methods of treating cancer using chemovirotherapy." This patent describes a diagnostic method for predicting a patient's response to chemovirotherapy or radiovirotherapy. The method involves exposing primary tumor cells from a patient, such as those obtained from brain tumors or pancreatic cancer, to a parvovirus and/or a chemotherapeutic agent or radiotherapy. The effectiveness of the treatment is determined by measuring the reduction of the expression or concentration of ISG15. Celina has 1 patent to her name.
Career Highlights
Throughout her career, Celina has worked with esteemed institutions, including the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Celina has collaborated with notable colleagues, including Nathalia Giese and Jens Werner. Their combined efforts have contributed to the development of innovative cancer treatment strategies.
Conclusion
Celina Czeipluch's work exemplifies the impact of innovative research in the medical field, particularly in cancer treatment. Her contributions continue to pave the way for advancements in patient care and therapeutic approaches.